A New Trade Framework for Global Healthcare R&D
Current business models for drug development are inefficient and ineffective - drugs are not reaching all who need them. Hubbard and Love contend that it is time to explore some alternatives
Guardat en:
| Publicat a: | PLoS Biol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
PLOS
2004
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC340954/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14966544/ https://ncbi.nlm.nih.govhttps://doi.org/10.1371/journal.pbio.0020052 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|